Danaher Co. (NYSE:DHR) Shares Acquired by Spinnaker Trust

Spinnaker Trust increased its position in shares of Danaher Co. (NYSE:DHRFree Report) by 19.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,802 shares of the conglomerate’s stock after acquiring an additional 775 shares during the period. Spinnaker Trust’s holdings in Danaher were worth $1,191,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of DHR. State Street Corp raised its position in shares of Danaher by 3.2% during the 2nd quarter. State Street Corp now owns 27,962,346 shares of the conglomerate’s stock worth $6,718,427,000 after acquiring an additional 866,600 shares in the last quarter. Moneta Group Investment Advisors LLC grew its stake in shares of Danaher by 96,490.5% in the 4th quarter. Moneta Group Investment Advisors LLC now owns 23,287,013 shares of the conglomerate’s stock valued at $6,180,839,000 after purchasing an additional 23,262,904 shares during the last quarter. Capital International Investors boosted its stake in shares of Danaher by 20.4% in the second quarter. Capital International Investors now owns 14,029,348 shares of the conglomerate’s stock valued at $3,366,677,000 after buying an additional 2,377,625 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Danaher by 4.3% in the second quarter. Geode Capital Management LLC now owns 13,459,741 shares of the conglomerate’s stock valued at $3,221,386,000 after buying an additional 559,056 shares in the last quarter. Finally, Bank of New York Mellon Corp raised its holdings in Danaher by 6.5% during the third quarter. Bank of New York Mellon Corp now owns 8,183,501 shares of the conglomerate’s stock worth $2,030,327,000 after purchasing an additional 502,868 shares during the last quarter. Institutional investors and hedge funds own 76.71% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the company. The Goldman Sachs Group cut Danaher from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $215.00 to $205.00 in a report on Thursday, December 7th. Raymond James boosted their price target on Danaher from $240.00 to $270.00 and gave the company an “outperform” rating in a research report on Wednesday, January 31st. Barclays downgraded Danaher from an “overweight” rating to an “equal weight” rating and set a $240.00 price target for the company. in a research report on Wednesday, January 24th. JPMorgan Chase & Co. upped their target price on Danaher from $250.00 to $270.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 20th. Finally, Citigroup upped their price objective on Danaher from $255.00 to $280.00 and gave the company a “buy” rating in a research note on Wednesday, January 31st. Seven analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $266.00.

Read Our Latest Analysis on Danaher

Danaher Stock Up 0.5 %

DHR opened at $246.33 on Monday. Danaher Co. has a 12 month low of $182.09 and a 12 month high of $248.78. The stock has a market cap of $182.02 billion, a P/E ratio of 38.55, a P/E/G ratio of 3.72 and a beta of 0.85. The stock’s 50 day moving average price is $228.78 and its 200 day moving average price is $231.88. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.68 and a quick ratio of 1.37.

Danaher (NYSE:DHRGet Free Report) last issued its quarterly earnings results on Tuesday, January 30th. The conglomerate reported $2.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.91 by $0.18. The company had revenue of $6.41 billion for the quarter, compared to analysts’ expectations of $6.10 billion. Danaher had a return on equity of 12.25% and a net margin of 17.26%. The firm’s revenue for the quarter was down 10.2% on a year-over-year basis. During the same period last year, the firm earned $2.87 EPS. As a group, research analysts predict that Danaher Co. will post 7.66 earnings per share for the current year.

Danaher Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, January 26th. Stockholders of record on Friday, December 29th were given a $0.24 dividend. The ex-dividend date was Thursday, December 28th. This represents a $0.96 annualized dividend and a dividend yield of 0.39%. Danaher’s dividend payout ratio (DPR) is presently 15.02%.

Danaher Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions.

Featured Articles

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.